SWOG clinical trial number
SWOG-8823
Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL2) in Patients with Colorectal Carcinoma
Closed
Phase
Accrual
14%
Abbreviated Title
Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL2) in Patients with Colorectal Carcinoma
Activated
04/01/1989
Closed
11/15/1990